Skip to content

Creditors' voluntary liquidation PHARMATRACK LIMITED

Barnet05542890-cvlOrder dated 27/12/2023Updated 22/09/2026, 21:34
More details available to registered users
Free access to practitioner details, reports and alerts

PHARMATRACK LIMITED in Barnet (East of England) entered creditors' voluntary liquidation. Mark Reynolds has been appointed as insolvency practitioner. The case reference is 05542890-cvl. The principal activity of PHARMATRACK LIMITED is management consultancy activities other than financial management. 4 reports are available.

General information

NamePHARMATRACK LIMITED
TownBarnet (East of England)
Company number05542890
Case no.05542890-cvl
StatusCreditors' voluntary liquidation
Order date27/12/2023
Company typePrivate limited company
Incorporated on22/08/2005
Company statusliquidation

Sector

GroupProfessional, scientific and technical activities
Primary codeManagement consultancy activities other than financial management (70229)

Offices and addresses

Registered office
C/O Valentine & Co Galley House, Moon Lane
EN5 5YL Barnet

Directors

Directors are visible after free registrationRegister free

Notices

27/12/2023Resolution
4518718
27/12/2023CompanyIssuedLiquidatorAppointment
4518685

Insolvency practitioner

Mark Reynolds
AddressC/O Valentine & Co Galley House, EN5 5YL Moon Lane
Practitioner contact details are visible after free registrationRegister free

InsolvencyIndex draws on public sources and makes every effort to keep the content of this page up to date and complete. Despite that care, the content may be incomplete or inaccurate. InsolvencyIndex provides the content of this website "as is", without any warranty as to its soundness, fitness for a particular purpose or otherwise. InsolvencyIndex accepts no liability for loss arising from, or in any way connected with, the use of this website or any inability to consult it. Save as set out in this disclaimer, InsolvencyIndex is not responsible for third-party files linked from this page; linking does not imply any endorsement of those files. Notices reproduced here are extracts from official publications; if you believe an entry is inaccurate, please contact us and we will correct it.